Overview

Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF)

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to assess the efficacy, safety, and tolerability of PLX-PAD intramuscular administration for the treatment of muscle injury following arthroplasty for HF.
Phase:
Phase 3
Details
Lead Sponsor:
Pluristem Ltd.